BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01356849-completion@plaintrial.com
DTSTAMP:20261029T121221Z
DTSTART;VALUE=DATE:201208
SUMMARY:Evaluate the Efficacy and Safety of Once Daily Administration of At
 rasentan Tablets (Low and High) Compared to Placebo in Reducing Residual A
 lbuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated Wi
 th the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) 
 Inhibitor — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01356849
URL:https://plaintrial.com/trial/NCT01356849
END:VEVENT
END:VCALENDAR